Cargando…
Use of Tofacitinib in the Management of COVID-19 Pneumonia
How to cite this article: Bande BD. Use of Tofacitinib in the Management of COVID-19 Pneumonia. Indian J Crit Care Med 2021; 25(10):1089–1090.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Jaypee Brothers Medical Publishers
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645822/ https://www.ncbi.nlm.nih.gov/pubmed/34916738 http://dx.doi.org/10.5005/jp-journals-10071-24004 |
| _version_ | 1784610389650046976 |
|---|---|
| author | Bande, Balasaheb D |
| author_facet | Bande, Balasaheb D |
| author_sort | Bande, Balasaheb D |
| collection | PubMed |
| description | How to cite this article: Bande BD. Use of Tofacitinib in the Management of COVID-19 Pneumonia. Indian J Crit Care Med 2021; 25(10):1089–1090. |
| format | Online Article Text |
| id | pubmed-8645822 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Jaypee Brothers Medical Publishers |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86458222021-12-15 Use of Tofacitinib in the Management of COVID-19 Pneumonia Bande, Balasaheb D Indian J Crit Care Med Editorial How to cite this article: Bande BD. Use of Tofacitinib in the Management of COVID-19 Pneumonia. Indian J Crit Care Med 2021; 25(10):1089–1090. Jaypee Brothers Medical Publishers 2021-10 /pmc/articles/PMC8645822/ /pubmed/34916738 http://dx.doi.org/10.5005/jp-journals-10071-24004 Text en Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd. https://creativecommons.org/licenses/by-nc/4.0/© The Author(s). 2021 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Editorial Bande, Balasaheb D Use of Tofacitinib in the Management of COVID-19 Pneumonia |
| title | Use of Tofacitinib in the Management of COVID-19 Pneumonia |
| title_full | Use of Tofacitinib in the Management of COVID-19 Pneumonia |
| title_fullStr | Use of Tofacitinib in the Management of COVID-19 Pneumonia |
| title_full_unstemmed | Use of Tofacitinib in the Management of COVID-19 Pneumonia |
| title_short | Use of Tofacitinib in the Management of COVID-19 Pneumonia |
| title_sort | use of tofacitinib in the management of covid-19 pneumonia |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645822/ https://www.ncbi.nlm.nih.gov/pubmed/34916738 http://dx.doi.org/10.5005/jp-journals-10071-24004 |
| work_keys_str_mv | AT bandebalasahebd useoftofacitinibinthemanagementofcovid19pneumonia |